Ignite Creation Date:
2025-12-24 @ 2:19 PM
Ignite Modification Date:
2026-01-27 @ 12:34 PM
Study NCT ID:
NCT05495295
Status:
RECRUITING
Last Update Posted:
2025-04-08
First Post:
2022-07-27
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
First-in-human Trial of PhOx430, a First-in-class Acetylglucosaminyltransferase V Inhibitor, in Advanced Solid Tumours
Sponsor:
Phost'In Therapeutics
Organization: